Abstract
Computational modeling of protein-ligand interactions plays a crucial role in drug discovery by enabling the prediction of binding affinities, identification of potential drug candidates, and optimization of lead compounds. This approach leverages molecular docking, molecular dynamics simulations, and other computational techniques to understand how small molecules interact with target proteins. In this article, we review the key computational methods used to model protein-ligand interactions, including their applications in virtual screening, drug optimization, and mechanistic studies. We also discuss the challenges and future directions in computational drug discovery, emphasizing the role of artificial intelligence and machine learning in enhancing predictive models.
All articles published in the American Journal of Bioinformatics (AJB) are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license, authors retain full copyright of their work and grant permission to anyone to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Conditions:
-
Attribution: Appropriate credit must be given to the original author(s) and the source, a link to the license must be provided, and any changes made must be indicated.
-
No additional restrictions: You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This open-access license ensures that scholarly work published in AJB is freely accessible and usable, promoting knowledge dissemination and academic collaboration worldw